ReShape Lifesciences Inc expected to post a loss of $4.21 a share - Earnings Preview

Vyome Holdings

12/05/2023 23:40

* ReShape Lifesciences Inc  RSLS.OQ   RSLS.O  is expected
to show
a rise in quarterly revenue when it reports  results on May 15. 
    * The San Clemente California-based  company is expected to
report
 a 3.0% increase in revenue to $2.513 million from $2.44 million
a year ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for ReShape
Lifesciences Inc
is for a loss of $4.21 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for ReShape
Lifesciences Inc is $17.75​, above​ its last closing price
of $2.38. ​​​

This summary was machine generated May 12 at 22:40 GMT.  All
figures in US dollars  unless otherwise stated